You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

General Solid Tumors

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor Trial in Beijing (XH001+ sintilimab)

Recruiting
  • Solid Tumor
  • XH001+ sintilimab
  • Beijing, Beijing, China
    PLA General Hospital
Jul 10, 2023

Locally Advanced or Metastatic Solid Tumors Trial in Guangzhou, Shanghai, Hangzhou (SM3321)

Recruiting
  • Locally Advanced or Metastatic Solid Tumors
  • Guangzhou, Guangdong, China
  • +2 more
Oct 17, 2023

Advanced Solid Tumor Trial in Beijing (QLS12004)

Not yet recruiting
  • Advanced Solid Tumor
  • Beijing, Beijing, China
    The Fifth Medical Center of the General Hospital of the Chinese
Apr 13, 2023

Advanced Solid Tumor Trial in Boston (TTX-MC138-NODAGA-Cu64)

Recruiting
  • Advanced Solid Tumor
  • Boston, Massachusetts
    Massachusetts General Hospital
Jun 14, 2023

Solid Tumor Trial in Shanghai (BEN101)

Not yet recruiting
  • Solid Tumor
  • BEN101
  • Shanghai, Shanghai, China
  • +1 more
Apr 14, 2023

Locally Advanced or Metastatic Solid Tumors Trial in Beijing (MSC-IFNa, Nab paclitaxel, Cyclophosphamide)

Recruiting
  • Locally Advanced or Metastatic Solid Tumors
  • MSC-IFNα
  • +3 more
  • Beijing, China
    Department of Biotherapeutic, Chinese PLA General Hospital
Jan 29, 2023

Advanced Solid Tumor Trial in Kuching (BL0020)

Not yet recruiting
  • Advanced Solid Tumor
  • Kuching, Malaysia
    Sarawak General Hospital
May 24, 2023

Solid Tumor, Adult Trial in China (GT201)

Recruiting
  • Solid Tumor, Adult
  • Beijing, Beijing, China
  • +3 more
Nov 17, 2023

Advanced Solid Tumor Trial in Beijing (QLF3108)

Recruiting
  • Advanced Solid Tumor
  • Beijing, Beijing, China
    Chinese People's Liberation Army (PLA) General Hospital
Aug 29, 2023

Advanced Solid Tumor Trial (SHR-A2009)

Recruiting
  • Advanced Solid Tumor
  • Beijing, Beijing, China
    Chinese PLA General Hospital-Department of Medical Oncology
Oct 20, 2022

Tumor Infiltrating Lymphocytes, Safety, Advanced Solid Tumor Trial in Beijing (TIL therapy)

Recruiting
  • Tumor Infiltrating Lymphocytes
  • +5 more
  • TIL therapy
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Dec 19, 2022

Solid Tumors, Adult, Solid Tumor, Mesothelioma (MPM) Trial in United States (IK-930)

Recruiting
  • Solid Tumors, Adult
  • +7 more
  • Boston, Massachusetts
  • +6 more
Jan 24, 2023

Advanced Solid Tumors Trial in Guangdong (JS019)

Recruiting
  • Advanced Solid Tumors
  • JS019
  • Guangdong, Guangzhou, China
    Guangdong General Hospital
Aug 17, 2022

Gastric Cancer, Pancreatic Cancer, Solid Tumor Trial in Beijing (KD-496)

Recruiting
  • Gastric Cancer
  • +2 more
  • KD-496
  • Beijing, China
    Chinese PLA General Hospital
Oct 13, 2022

Advanced Solid Tumor Trial in Bethesda, Boston (STAR0602)

Recruiting
  • Advanced Solid Tumor
  • Bethesda, Maryland
  • +1 more
Jan 6, 2023

Locally Advanced Unresectable or Metastatic Solid Tumors Trial in China (SG1906)

Recruiting
  • Locally Advanced Unresectable or Metastatic Solid Tumors
  • Beijing, Beijing, China
  • +8 more
May 12, 2023

Solid Tumor, Unspecified, Adult Trial in United States (RLY-1971)

Completed
  • Solid Tumor, Unspecified, Adult
  • Lake Mary, Florida
  • +5 more
Jan 30, 2023

Malignant Tumor, Malignant Tumor of Brain Trial in Taiwan (NBM-BMX Capsule, Temozolomide, Standard radiotherapy)

Recruiting
  • Malignant Neoplasm
  • Malignant Neoplasm of Brain
  • NBM-BMX Capsule
  • +2 more
  • Hualien City, Taiwan
  • +4 more
Aug 22, 2023

Solid Tumors, Adult Trial in Beijing (GT101)

Recruiting
  • Solid Tumors, Adult
  • GT101
  • Beijing, Beijing, China
    The fifth medical center of the General Hospital of the Chinese
Jun 27, 2022

Breast Cancer, Gastric Cancer, Gastroesophageal-junction Cancer Trial in Australia (IKS014)

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Concord, New South Wales, Australia
  • +4 more
May 30, 2023

Solid Tumors Trial in United States (mRNA-4157, Pembrolizumab)

Recruiting
  • Solid Tumors
  • mRNA-4157
  • Pembrolizumab
  • Tucson, Arizona
  • +9 more
Sep 20, 2022

Metastatic Malignant Tumor Trial in United States (NPX267)

Not yet recruiting
  • Metastatic Malignant Neoplasm
  • Baltimore, Maryland
  • +5 more
Jul 21, 2023

Solid Tumor, Unspecified, Adult Trial in Taipei (MPB-1734)

Recruiting
  • Solid Tumor, Unspecified, Adult
  • Taipei, Taiwan
    Taipei Veterans General Hospital
Apr 27, 2022

Malignant Solid Tumors Trial in Beijing (2-4 mCi 68Ga/64Cu-FAPI-XT117, 4-6 mCi 68Ga/64Cu-FAPI-XT117, 6-8 mCi

Recruiting
  • Malignant Solid Tumors
  • 2-4 mCi 68Ga/64Cu-FAPI-XT117
  • +2 more
  • Beijing, China
    the First Medical Center, Chinese PLA General Hospital
Apr 3, 2023

Advanced Solid Tumor Trial in Australia, United States (Mirdametinib, BGB-3245)

Recruiting
  • Advanced Solid Tumor
  • La Jolla, California
  • +5 more
Jan 26, 2023